GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Average Recommendation of “Hold” from Analysts

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has received an average recommendation of “Hold” from the fourteen research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $89.8333.

Several research firms have recently commented on GEHC. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. BTIG Research reissued a “buy” rating and set a $87.00 price target on shares of GE HealthCare Technologies in a report on Friday, November 21st. Bank of America raised their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Wells Fargo & Company lowered their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research report on Thursday, October 30th. Finally, Jefferies Financial Group boosted their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $81.75 on Tuesday. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $37.24 billion, a PE ratio of 16.89, a price-to-earnings-growth ratio of 3.18 and a beta of 1.08. The firm’s 50 day moving average price is $81.46 and its 200-day moving average price is $77.09. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. During the same period in the previous year, the business posted $1.14 earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities research analysts expect that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. increased its position in shares of GE HealthCare Technologies by 4.2% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 159,882 shares of the company’s stock worth $11,842,000 after acquiring an additional 6,479 shares during the period. Wedge Capital Management L L P NC bought a new position in GE HealthCare Technologies in the third quarter worth approximately $26,859,000. Valicenti Advisory Services Inc. raised its position in GE HealthCare Technologies by 22.6% during the 3rd quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock valued at $5,115,000 after purchasing an additional 12,550 shares in the last quarter. Lineweaver Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth $592,000. Finally, National Bank of Canada FI lifted its holdings in shares of GE HealthCare Technologies by 133.3% in the 2nd quarter. National Bank of Canada FI now owns 899,693 shares of the company’s stock worth $66,640,000 after buying an additional 514,007 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.